NCONTACT COAGULATION SYSTEM KIT

K062539 · Ncontact Surgical, Inc. · GEI · Dec 1, 2006 · General, Plastic Surgery

Device Facts

Record IDK062539
Device NameNCONTACT COAGULATION SYSTEM KIT
ApplicantNcontact Surgical, Inc.
Product CodeGEI · General, Plastic Surgery
Decision DateDec 1, 2006
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.4400
Device ClassClass 2
AttributesTherapeutic

Intended Use

The nContact Coagulation System is intended for the coagulation of soft tissue using radiofrequency (RF) energy.

Device Story

The nContact Coagulation System is a sterile, single-use, disposable electrosurgical device used for soft tissue coagulation. It consists of a flexible, cooled electrode with a suction stabilizer feature. The device connects to a non-sterile, reusable electrosurgical generator via a sterile instrument cable to transmit radiofrequency (RF) energy to the target tissue. It is intended for use by clinicians in a surgical setting. The suction stabilizer assists in positioning and maintaining contact with the tissue during the coagulation process. By delivering controlled RF energy, the device enables effective tissue coagulation, which can assist in surgical procedures requiring hemostasis or tissue ablation.

Clinical Evidence

Bench testing only. No clinical data provided.

Technological Characteristics

Electrosurgical coagulation device; flexible, cooled electrode with suction stabilizer; RF energy source; sterile, single-use electrode; non-sterile, reusable electrosurgical generator; instrument cable connectivity.

Indications for Use

Indicated for the coagulation of soft tissue using radiofrequency (RF) energy.

Regulatory Classification

Identification

An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ # 11062539 510(k) Summary: | Application Date: | August 25, 2006 | |----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Sponsor: | nContact Surgical, Inc.<br>2880 Slater Road, Suite 103,<br>Morrisville, NC 27560 | | Correspondent: | Jane Ricupero<br>Director of Regulatory & Quality<br>2880 Slater Road, Suite 103,<br>Morrisville, NC 27560 | | Contact Numbers: | Phone: 919 466-9810 x3013<br>Fax: 919 466-9811 | | Device Proprietary Name: | nContact Coagulation System<br>Model number: CSK | | Device Common Name: | Electrosurgical device and<br>accessories | | Device Classification: | 21 CFR 878.4400 | | Product Code: | GEI | | Classification Name: | Electrosurgical cutting and<br>coagulation device and accessories | | Predicate Device(s): | Electrosurgical Cutting & Coagulation<br>Device | | Predicate Device Classification: | 21 CFR 878.4400 | | Predicate Device Descriptions: | 1. Medtronic, Inc., Cardioblate Bipolar<br>Radiofrequency Ablation System<br>(K031247)<br>2. Arthrocare, Corporation<br>Electrosurgery System (K992972)<br>3. Arthrocare, Corporation<br>Electrosurgery System (K971532)<br>4. Boston Scientific, Electrosurgical<br>System (K981981) | {1}------------------------------------------------ ### Device Description: The nContact Coagulation System consists of a sterile, single-use, disposable coagulation electrode device (2cm & 5cm sizes provided) intended to be used to coagulate soft tissue. The flexible, cooled electrode device, with a suction stabilizer feature, transmits radiofrequency (RF) energy from an Electrosurgical Generator (non-sterile, re-useable) connected through an Instrument Cable (sterile). #### Intended Use: The nContact Coagulation System is intended for the coagulation of soft tissue using radiofrequency (RF) energy. ### Non-clinical Performance: The nContact Coagulation System has been compared to the listed predicate devices with respect to intended use, technological characteristics, and principle of operation. Performance testing was completed to validate its intended use. All of the features specified for the subject device are covered by those listed in at least one predicate device. #### Substantial Equivalence: The nContact Coagulation System may be considered substantially equivalent to the predicate devices based on performance and comparative data, and does not raise new questions of safety and efficacy. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with its wings spread, facing left. The eagle is composed of three thick, curved lines. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 DEC - 1 2006 nContact Surgical, Inc. % Ms. Jane Ricupero Director, Regulatory and Ouality 2880 Slater Road, Suite 103 Morrisville, North Carolina 27560 Re: K062539 Trade/Device Name: nContact Coaguation System Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: II Product Code: GEI Dated: November 22, 2006 Received: November 24, 2006 Dear Ms. Ricupero: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ Page 2 - Ms. Jane Ricupero This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Mark N. Mellon Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## Indications for Use 510(k) Number (if known): _1062539 Device Name: nContact Coagulation System Indications for Use: The nContact Coagulation System is intended for the coagulation of soft tissue using Radiofrequency (RF) energy. | Prescription Use<br>(Part 21 CFR 801 Subpart D) | X | AND/OR | Over-The-Counter Use<br>(21 CFR 801 Subpart C) | |-------------------------------------------------|---|--------|------------------------------------------------| |-------------------------------------------------|---|--------|------------------------------------------------| (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) | Division Sign-Off | |---------------------------------------------------------------| | Division of General, Restorative,<br>and Neurological Devices | | Section 4 - Indications for Use Statement<br>Page 4-1 of 4-1 | |--------------------------------------------------------------| |--------------------------------------------------------------| | 510(k) Number | L0625235 | |---------------|----------| |---------------|----------|
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%